Now:HOME > ACADEMIC CONFERENCE >Conference Notice
Establishing rheumatism communication platform to improve clinical diagnosis and treatment
Author:管理员  Addtime:2021-01-19
  • In order to promote the development of rheumatic immunology, we should study the clinical experience and academic achievements of rheumatic immunology together. On January 15-16,2020, the 2021 symposium on hot spots of rheumatism hosted by the Chengdu high-tech Medical Association was successfully held. In response to the call for national epidemic prevention and control, the number of participants at the conference site was controlled. The conference was held in an online + offline mode, a total of more than 100 relevant medical workers attended the meeting.

  • 640 (5).png

  • Professor Zhu Jing of the Sichuan Provincial People's Hospital, Professor Zeng Fanxin of the Dazhou Central Hospital and Professor Wu Jianhong were invited to deliver opening speeches, professor Su Jiang of the Sichuan Provincial People's Hospital, professor LV Liwei of the University of Hong Kong, Professor Liu Jianping of the Affiliated Hospital of the North Sichuan Medical College and dozens of other experts and scholars were also invited to give lectures on the diagnosis and treatment of organ damage associated with Ra, the whole course management of ankylosing spondylitis therapy, inflammatory and non-inflammatory mechanisms of refractory Ra, and imaging diagnosis of SACROILIAC arthritis.

  • At the meeting, experts also focused on the latest hot topics of rheumatic immune diseases in 2020, clinical diagnosis and treatment progress, treatment strategies, new technologies and new applications, as well as the pathogenesis of discussion and other topics launched a heated discussion. The convening of this conference has successfully set up a platform for the exchange and study of Rheumatic Immune Diseases, which will help advance the process of multi-disciplinary standardized comprehensive treatment of Rheumatic Immune Diseases and further promote the development of rheumatic immunity.